Recent Study: Brain Tumor - Pipeline Assessment and Market Forecasts to 2017

Jan. 17, 2011 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Brain tumor- Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global BRAIN TUMORmarket. The report identifies the key trends shaping and driving the global brain tumor market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global brain tumor sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimated the global brain tumor market to be at $914m in 2009, and forecasts it to grow at 11% annually for the next seven years to reach $2.1 billion by 2017. More novel therapies are expected to launch and this factor acts as a major driver for the market. The current market has three products approved for the treatment of brain tumors and there is a high opportunity for the pipeline products to enter into this potential market.

Scope

The report provides information on the key drivers and challenges of the brain tumor market. Its scope includes:

* Annualized global brain tumor market revenues data from 2001 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as DNA replication inhibitor, VGEF inhibitor, Tyrodine Kinase inhibitor and Toposiomerase inhibitor.
* Analysis of the current and future competition in the global brain tumor market. Key market players covered are Antisense Pharma, Pfizer, EMD Sereno, AstraZeneca, Bristol-myers Squibbs, Amgen.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the brain tumor therapeutics market.


Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global brain tumor market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global brain tumor market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global brain tumor market landscape? - Identify, understand and capitalize.



For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/109276_brain_tumor_pipeline_as...


Partial Table of Contents:

1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Disease Overview 5
2.1 Marketed Drugs 7
2.2 GlobalData Pipeline Report Guidance 8
3 Brain Tumor Therapeutics: Market Characterization 9
3.1 Brain Tumor Market Size 9
3.2 Brain Tumor Market Forecast and CAGR 9
3.3 Drivers and Barriers for Brain Tumor Market 11
3.3.1 Drivers for Brain Tumor Market 11
3.3.2 Barriers for Brain Tumor Market 11
3.4 Opportunity and Unmet Need 12
3.5 Key Takeaway 13
4 Brain Tumor Therapeutics: Competitive Assessment 14
4.1 Overview 14
4.2 Strategic Competitor Assessment 14
4.3 Product Profiles for Major Marketed Products in the Brain Tumor Market 15
4.3.1 Temodar 15
4.3.2 Avastin 16
4.3.3 Gliadel 17
4.4 Major Marketed Products Comparison in Brain Tumor Market 18
4.5 Key Takeaway 18
5 Brain Tumor Therapeutics: Pipeline Assessment 19
5.1 Overview 19
5.2 Strategic Pipeline Assessment 19
5.2.1 Technology Trends Analytic Framework 19
5.3 Brain Tumor Therapeutics - Promising Drugs under Clinical Development 21
5.4 Molecule Profile for Promising Drugs Under Clinical Development 22
5.4.1 Cilengitide 22
5.4.2 Trabedersen 23
5.4.3 Neuradiab 24
5.5 Brain Tumor Therapeutics Market - Clinical Pipeline by Mechanism of Action 25
5.6 Brain Tumor Pipeline - Pipeline by Clinical Phases of Development 26
5.6.1 Brain Tumor Therapeutics - Regulatory and Phase III Clinical Pipeline 27
5.6.2 Brain Tumor Therapeutics - Phase II Clinical Pipeline 28
5.6.3 Brain Tumor Therapeutics - Phase I Clinical Pipeline 30
5.6.4 Brain Tumor Therapeutics - Preclinical Pipeline 32
5.7 Key Takeaway 32
6 Brain Tumor Therapeutics: Implications for Future Market Competition 33
7 Brain Tumor Therapeutics: Future Players in the Brain Tumor Market 34
7.1 Introduction 34
7.2 AstraZeneca 34
7.2.1 Company Overview 34
7.2.2 Business Description 35
7.3 Antisense Pharma 37
7.3.1 Company Overview 37
7.4 EMD Serono, Inc. 38
7.4.1 Company Overview 38
7.5 GlaxoSmithKline plc. 38
7.5.1 Company Overview 38
7.5.2 Business Description 39
7.6 Bristol-Myers Squibb 42
7.6.1 Company Overview 42
7.6.2 Business Description 42
7.7 Pfizer Inc. 44
7.7.1 Company Overview 44
7.7.2 Business Description 44
7.8 F. Hoffmann-La Roche Ltd (Roche) 48

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1092...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.